visken tablet
xediton pharmaceuticals inc - pindolol - tablet - 10mg - pindolol 10mg - beta-adrenergic blocking agents
visken- pindolol tablet
novartis pharmaceuticals corporation - pindolol (unii: bj4hf6iu1d) (pindolol - unii:bj4hf6iu1d) - tablet - 5 mg - visken® (pindolol) is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. visken® (pindolol) is contraindicated in: 1) bronchial asthma; 2) overt cardiac failure; 3) cardiogenic shock; 4) second and third degree heart block; 5) severe bradycardia. (see warnings)
visken
novartis new zealand ltd - pindolol 10mg; - tablet - 10 mg - active: pindolol 10mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose
apo-pindol tab 10mg tablet
apotex inc - pindolol - tablet - 10mg - pindolol 10mg - beta-adrenergic blocking agents
pindolol-10 tab 10mg tablet
pro doc limitee - pindolol - tablet - 10mg - pindolol 10mg - beta-adrenergic blocking agents
visken tablet
xediton pharmaceuticals inc - pindolol - tablet - 5mg - pindolol 5mg - beta-adrenergic blocking agents
visken 5mg tablets
advanz pharma - pindolol - oral tablet - 5mg
visken tablets 5 mg milligram
novartis pharmaceuticals uk ltd - pindolol - tablets - 5 mg milligram
visken tablet
tribute pharmaceuticals canada inc - pindolol - tablet - 15mg - pindolol 15mg - beta-adrenergic blocking agents
visken 15mg tablets
advanz pharma - pindolol - oral tablet - 15mg